Effect of disintegrates and metabolites of Lactobacillus rhamnosus and Saccharomyces boulardii on biofilms of antibiotic resistant conditionally pathogenic and pathogenic bacteria
AbstractThe work presented here is the first to examine the impact of Lactobacillus rhamnosus GG ATCC 53103 and Saccharomyces boulardii metabolites obtained using the author`s method on the formation of biofilm forms of bacteria. The structural components of the probiotic microorganisms were obtained using the method of physical disintegration – low frequency ultrasound waves produced by a G3-109 generator. Metabolites were obtained by cultivating L. rhamnosus and S. boulardii in ultrasound disintegrates of lactobacteria and Saccharomycetes. The impact of biologically active substances on the formation of biofilm of Corynebacterium ulcerans tox+ 112, C. diphtheriae gravis tox+ 108, by antibiotic-resistant Pseudomonas aeruginosa PR, Klebsiella pneumoniae PR, Lelliottia amnigena (Enterobacter amnigenus) PR and P. aeruginosa AТСС 27853 reference strain was studied using the spectrophotometric method. For the first time, we proved that L. rhamnosus GG and S. boulardii metabolites and combinations of metabolites of Saccharomycetes and lactobacteria, obtained by cultivating primary producers in their disintegrates, damage preformed 24-hour biofilms of gram-positive and gram-negative bacteria. The representatives of Corynebacterium exhibited higher sensitivity to the filtrates of disintegrates and products of vital activity of lactobacteria and Saccharomycetes than gram-negative pathogens. High parameters of decrease in optical density of preformed biofilms of Corynebacterium and antibiotic-resistant gram-negative bacteria were observed under the influence of combination of L. rhamnosus GG and S. boulardii metabolites (by 1.3–2.6 times). However, the largest reduction of the optical density of the formed biofilm of all studied strains was observed under the influence of metabolites of lactobacteria (by 1.5–5.3 times). Biologically active substances of L. rhamnosus GG and S. boulardii obtained using the author’s method can be used as candidate preparations which could have a strong influence on the process of the formation of the biofilms and preformed biofilms, and also as a preparations of substitution/addition of therapeutic prescription.
Al-Mathkhury, H. J. F., & Abed Assal, S. D. (2012). Inhibitory effect of lactoba cilli filtrate on Klebsiella pneumoniae biofilm. The Iraqi Postgraduate Medi cal Journal, 11(2), 169–181.
Arciola, C. R., Campoccia, D., Speziale, P., Montanaro, L., & Costerton, J. W. (2012). Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials, 33(26), 5967–5982.
Bousquet, J., & Khaltaev, N. (2007). Global surveillance, prevention and control of chronic respiratory diseases: A comprehensive approach. World Health Organization, Geneva, Switzerland.
De Marco, S., Piccioni, M., Muradyan, D., Zadra, C., Pagiotti, R., & Pietrella, D. (2017). Antibiofilm and antiadhesive activities of different synbiotics. Journal of Probiotics and Health, 5, 182.
Di Luca, M., Maccari, G., & Nifosì, R. (2014). Treatment of microbial biofilms in the post-antibiotic era: Prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools. Pathogens and Disease, 70(3), 257–270.
Dzhoraeva, S. K., Goncharenko, V. V., Shchegoleva, E. V., Shcherbakova, J. V., & Bezruchenko, A. A. (2015). Sostav i funktcii mikrobiotcenozov razlich nykh biotopov makroorganizma i klinicheskaia znachimost ikh narushenii [Composition and functions of microbiocenoses of different biotopes of the macroorganism and clinical significance of their disorders dermatology and venerology]. Dermatologіia ta Venerologіia, 68(2), 5–19 (in Russian).
Frickmann, H., Warnke, P., Klenk, C., & Redanz, S. (2018). Influence of probiotic culture supernatants on in vitro biofilm formation of staphylococci. European Journal of Microbiology and Immunology, 8(4), 119–127.
Gabrielyan, N. I., Gorskaya, E. M., Romanova, N. I., & Tsirulnikova, O. M. (2012). Gospital'naja mikroflora i bioplenki [Nosocomial infection and microbial biofilms in surgery]. Russian Journal of Transplantology and Artificial Or gans, 14(3), 83–91 (in Russian).
Golub, A. V. (2012). Bakterialnye bioplenki – novaia cel’ terapii? [Bacterial bio films – A new therapeutic target?]. Clinical Microbiology and Antimicrobial Chemotherapy, 14(1), 23–30 (in Russian).
Gupta, R., & Srivastava, S. (2014). Antifungal effect of antimicrobial peptides (AMPs LR14) derived from Lactobacillus plantarum strain LR/14 and their applications in prevention of grain spoilage. Food Microbiology, 42, 1–7.
Haney, E. F., Trimble, M. J., Cheng J. T., Vallé, Q., & Hancock, R. W. (2018). Critical assessment of methods to quantify biofilm growth and evaluate antibiofilm activity of host defence peptides. Biomolecules, 8(2), 29.
He, J., Luo, X., Jin, D., Wang, Y., & Zhang, T. (2018). Identification, recombinant expression, and characterization of LHG2, a novel antimicrobial peptide of Lactobacillus casei HZ1. Molecules, 23(9), 2246.
Lagun, L. V., & Zhavoronok, S. V. (2013). Bakterialnye bioplenki i ikh rol v raz vitii infektcii mochevyvodiashchikh putei [Bacterial biofilms and their role in the development of urinary tract infections]. Meditcinskii Zhurnal, 4, 21–27 (in Russian).
Mathur, H., Rea, M. C., Field, D., & Ross, R. P. (2018). Fighting biofilms with lantibiotics and other groups of bacteriocins. Bioﬁlms and Microbiomes, 4(9), 2–13.
Mishra, B., Reiling, S., Zarena, D., & Wang, G. (2017). Host defense antimicro bial peptides as antibiotics: Design and application strategies. Current Opini on in Chemical Biology, 38, 87–96.
Nantavisai, K, Puttikamonkul, S., Chotelersak, K., & Taweechotipatr, M. (2018). In vitro adhesion property and competition against enteropathogens of Lacto bacillus strains isolated from Thai infants. Songklanakarin Journal of Science and Technology, 40(1), 69–74.
Ołdak, A., & Zielińska, D. (2017). Bacteriocins from lactic acid bacteria as an alternative to antibiotics. Postepy Postȩpy Higieny i Medycyny Doświadczal nej, 71(1), 328–338.
Osama, D. M., Elkhatib, W. F., Tawfeik, A. M., Aboulwafa, M. M., & Hassouna, N. A.-H. (2017). Antimicrobial, antibiofilm and immunomodulatory activities of Lactobacillus rhamnosus and Lactobacillus gasseri against some bacterial pathogens. International Journal of Biotechnology for Wellness Industries, 6(1), 12–21.
Rybalchenko, O. V., Bondarenko, V. M., & Orlova, O. G. (2014). Ultrastruktura bioplenok pri vnutrividovom i mezhvidovym vzaimodeistvii uslovno pato gennykh bakterij [Ultrastructure of biofilms with intraspecific and interspecific interactions of conditionally pathogenic bacteria]. Bjulleten' Orenburgskogo Nauchnogo Centra, 1, 1–11 (in Russian).
Rybalchenko, O. V., Bondarenko, V. M., Orlova, O. G., Larionov, I. V., & Fialkina, S. V. (2010). Dezorganizatciia bioplenok klinicheskikh shtammov stafilokok kov metabolitami laktobatcill [Disorganization of biofilms of clinical staphy lococcal strains by lactobacillus metabolites]. Zhurnal Mikrobiologii, Epide miologii i Immunobiologii, 6, 66–70 (in Russian).
Sahib, F. H., Aldujaili, N. H., & Alrufae, M. M. (2017). Biosynthesis of silver nanoparticles using saccharomyces boulardii and study their biological acti vities. European Journal of Pharmaceutical and Medical Research, 4(9), 65–74.
Shaikh, A. M., & Sreeja, V. (2017). Metabiotics and their health benefits. Interna tional Journal of Fermented Foods, 6(1), 11–23.
Stepanović, S., Vuković, D., Hola, V., Bonaventura, G., Djukić, S., Ćirković, I., & Ruzicka, F. (2007). Quantification of biofilm in microtiter plates: Overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS, 115(8), 891–899.
Tkachenko, T. (2017). Smogut li antimikrobnye peptidy zamenit antibiotiki? [Will antimicrobial peptides be able to replace antibiotics?]. Farmatcevt Praktik, 3, 16–18 (in Russian).
Urgent need for new antibiotics to tackle antimicrobial resistance, says WHO (2017). The Pharmaceutical Journal, 299; 7905.
Wang, D., Haapasalo, M., Gao, Y., Ma, J., & Shen, Y. (2018). Antibiofilm peptides against biofilms on titanium and hydroxyapatite surfaces. Bioactive Mate rials, 3(4), 418–425.
Wang, D., Shen, Y., Hancock, R. E. W., Ma, J., & Haapasalo, M. (2018). Antimicrobial effect of peptide djk-5 used alone or mixed with edta on mono- and multispecies biofilms in dentin canals. Journal of Endodontics, 44(11), 1709–1713.
Wang, H. Y., Cheng, J. W., Yu, H. Y., Lin, L., Chih, Y. H., & Pan, Y. P. (2015). Efficacy of a novel antimicrobial peptide against periodontal pathogens in both planktonic and polymicrobial biofilm states. Acta Biomaterialia, 25, 150–161.
Wang, Z., Shen, Y., & Haapasalo, M. (2017). Antibiofilm peptides against oral biofilms. Journal of Oral Microbiology, 9(1), 1327308.
Zhou, B., & Zhang, D. (2018). Antibacterial effects of bacteriocins isolated from Lactobacillus rhamnosus (ATCC 53103) in a rabbit model of knee implant infection. Experimental and therapeutic medicine, 15(3), 2985–2989.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.